Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage

Introduction It is common to start all patients on chemical prophylaxis for deep vein thrombosis (DVT) in order to decrease the risk of venous thromboembolism (VTE) and the associated adverse effects, including the potential for fatal pulmonary embolism (PE). There is no consensus in the literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Farr, Saman, Toor, Harjyot, Patchana, Tye, Podkovik, Stacey, Wiginton, James G, Sweiss, Raed, Wacker, Margaret Rose, Miulli, Dan E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Quality Improvement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://www.ncbi.nlm.nih.gov/pubmed/31754562
http://dx.doi.org/10.7759/cureus.5827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://www.ncbi.nlm.nih.gov/pubmed/31754562
http://dx.doi.org/10.7759/cureus.5827

Ejemplares similares